COLGATE PALMOLIVE CO·4

Feb 9, 4:16 PM ET

Massey Sally 4

4 · COLGATE PALMOLIVE CO · Filed Feb 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Colgate (CL) CHRO Sally Massey Exercises Options and Sells Shares

What Happened

  • Sally Massey, Chief Human Resources Officer of Colgate-Palmolive (CL), exercised 15,851 stock options (code M) and immediately sold the 15,851 shares in an open-market transaction (code S) on Feb 5, 2026.
  • Exercise cost reported: 15,851 shares × $76.41 = $1,211,175. Sale proceeds reported: 15,851 shares × weighted average $95.03 = $1,506,287. A derivative disposition of 15,851 shares at $0 is also reported (related to the option exercise/tax withholding).

Key Details

  • Transaction date: 2026-02-05; Form 4 filed 2026-02-09 (timely — within the required reporting window).
  • Exercise price / cash paid: $76.41 per share; sale weighted average price: $95.03 (shares sold across prices $95.02–$95.045; see footnote F3).
  • Reported values: exercise cost ≈ $1.21M; gross sale proceeds ≈ $1.51M.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Relevant footnotes from the filing:
    • F1: Options awarded under the issuer’s incentive compensation plan.
    • F2: Portion of sale proceeds delivered to issuer to cover option exercise price and related tax withholding (i.e., same-day/cashless settlement behavior).
    • F3: Weighted-average sale price; multiple sale prices within a narrow range.
    • F4: Options vested in one-third increments beginning 1 year after the Sept 10, 2020 grant date.

Context

  • This pattern — exercising options and immediately selling the resulting shares — is a common way for insiders to monetize compensation and cover exercise costs and taxes (a cashless or same-day sale). It is generally a routine liquidity event rather than a clear bullish statement about the stock.
  • No indication in the filing that this was a 10% owner transaction, a gift, or part of a 10b5-1 plan; the filing attributes transactions to standard option exercise and sale under the company’s incentive plan.

Insider Transaction Report

Form 4
Period: 2026-02-05
Massey Sally
Chief Human Resources Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-05$76.41/sh+15,851$1,211,17529,602 total
  • Sale

    Common Stock

    [F2][F3]
    2026-02-05$95.03/sh15,851$1,506,28713,751 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F4]
    2026-02-0515,8510 total
    Exercise: $76.41Exp: 2028-09-10Common Stock (15,851 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,111
Footnotes (4)
  • [F1]Exercise of stock options awarded under the issuer's incentive compensation plan.
  • [F2]Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
  • [F3]Weighted average price, as these shares were sold in multiple transactions at prices ranging from $95.02 to $95.045 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact|2026-02-09

Documents

1 file
  • 4
    doc4.xmlPrimary